Erythropoietin administration partially prevents adipose tissue loss in experimental cancer cachexia models

Journal of Lipid Research

Volumn 54, Issue 11, 2013, Pages 3045-3051

  Penna, Fabio ^a,b   Busquets, Silvia ^a   Toledo, Miriam ^a   Pin, Fabrizio ^b   Massa, David ^a   López Soriano, Francisco J ^a   Costelli, Paola ^b   Argilés, Josep M ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Anemia; Lipogenesis; Lipolysis; Lipoprotein lipase

Indexed keywords

ERYTHROPOIETIN RECEPTOR; LIPOPROTEIN LIPASE; RECOMBINANT ERYTHROPOIETIN; TRIACYLGLYCEROL;

ADIPOCYTE; ADIPOSE TISSUE; ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCITES HEPATOMA; CACHEXIA; CELL DIFFERENTIATION; COLON CARCINOMA; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; GASTROCNEMIUS MUSCLE; HEMATOCRIT; IN VITRO STUDY; LEWIS CARCINOMA; LIPOGENESIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANEMIA; LIPOGENESIS; LIPOLYSIS; LIPOPROTEIN LIPASE;

3T3-L1 CELLS; ADIPOSE TISSUE; ANIMALS; CACHEXIA; CELL DIFFERENTIATION; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; ERYTHROPOIETIN; MALE; MICE; MUSCLE, SKELETAL; NEOPLASMS; RATS; RECEPTORS, ERYTHROPOIETIN;

EID: 84886042705     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M038406     Document Type: Article

References (30)

1. Muscaritoli, M., S. D. Anker, J. Argilés, Z. Aversa, J. M. Bauer, G. Biolo, Y. Boirie, I. Bosaeus, T. Cederholm, P. Costelli, et al. 2010. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics". Clin. Nutr. 29: 154-159.
2. Muscaritoli, M., M. Bossola, Z. Aversa, R. Bellantone, and F. Rossi Fanelli. 2006. Prevention and treatment of cancer cachexia: new insights into an old problem. Eur. J. Cancer. 42: 31-41. (Pubitemid 41814530)
3. Loberg, R. D., D. A. Bradley, S. A. Tomlins, A. M. Chinnaiyan, and K. J. Pienta. 2007. The lethal phenotype of cancer: the molecular basis of death due to malignancy. CA Cancer J. Clin. 57: 225-241. (Pubitemid 47312082)
4. Bruera, E., and C. Sweeney. 2000. Cachexia and asthenia in cancer patients. Lancet Oncol. 1: 138-147.
5. Knight, K., S. Wade, and L. Balducci. 2004. Prevalence and outcomes of anemia in cancer: a systematic review of the literature. Am. J. Med. 116 (Suppl. 7A): 11S-26S.
6. Caro, J. J., M. Salas, A. Ward, and G. Goss. 2001. Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer. 91: 2214-2221. (Pubitemid 32552805)
7. Drochioiu, G. 2008. Chronic metabolic acidosis may be the cause of cachexia: body fluid pH correction may be an effective therapy. Med. Hypotheses. 70: 1167-1173.
8. Chiba, T., Y. Ikawa, and K. Todokoro. 1991. GATA-1 transactivates erythropoietin receptor gene, and erythropoietin receptor-mediated signals enhance GATA-1 gene expression. Nucleic Acids Res. 19: 3843-3848. (Pubitemid 21912750)
9. Jelkmann, W. 2007. Erythropoietin after a century of research: younger than ever. Eur. J. Haematol. 78: 183-205.
10. Lindholm, E., P. Daneryd, U. Korner, A. Hyltander, M. Fouladiun, and K. Lundholm. 2004. Effects of recombinant erythropoietin in palliative treatment of unselected cancer patients. Clin. Cancer Res. 10: 6855-6864. (Pubitemid 39383034)
11. Lundholm, K., P. Daneryd, I. Bosaeus, U. Körner, and E. Lindholm. 2004. Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease: effects on survival, metabolism, and function. Cancer. 100: 1967-1977. (Pubitemid 38529575)
12. Shasha, D., M. J. George, and L. B. Harrison. 2003. Once-weekly dosing of epoetin-alpha increases hemoglobin and improves quality of life in anemic cancer patients receiving radiation therapy either concomitantly or sequentially with chemotherapy. Cancer. 98: 1072-1079. (Pubitemid 37022110)
13. Ogilvie, M., X. Yu, V. Nicolas-Metral, S. M. Pulido, C. Liu, U. T. Ruegg, and C. T. Noguchi. 2000. Erythropoietin stimulates proliferation and interferes with differentiation of myoblasts. J. Biol. Chem. 275: 39754-39761. (Pubitemid 32059005)
14. Penna, F., D. Costamagna, A. Fanzani, G. Bonelli, F. M. Baccino, and P. Costelli. 2010. Muscle wasting and impaired myogenesis in tumor bearing mice are prevented by ERK inhibition. PLoS ONE. 5: e13604.
15. Rotter, R., M. Menshykova, T. Winkler, G. Matziolis, I. Stratos, M. Schoen, T. Bittorf, T. Mittlmeier, and B. Vollmar. 2008. Erythropoietin improves functional and histological recovery of traumatized skeletal muscle tissue. J. Orthop. Res. 26: 1618-1626.
16. Hamed, S., D. Egozi, D. Kruchevsky, L. Teot, A. Gilhar, and Y. Ullmann. 2010. Erythropoietin improves the survival of fat tissue after its transplantation in nude mice. PLoS ONE. 5: e13986.
17. Lippman, M. M., W. R. Laster, B. J. Abbott, J. Venditti, and M. Baratta. 1975. Antitumor activity of macromomycin B (NSC 170105) against murine leukemias, melanoma, and lung carcinoma. Cancer Res. 35: 939-945.
18. Tessitore, L., P. Costelli, G. Bonetti, and F. M. Baccino. 1993. Cancer cachexia, malnutrition, and tissue protein turnover in experimental animals. Arch. Biochem. Biophys. 306: 52-58. (Pubitemid 23291282)
19. Ramirez, I., A. J. Kryski, O. Ben-Zeev, M. C. Schotz, and D. L. Severson. 1985. Characterization of triacylglycerol hydrolase activities in isolated myocardial cells from rat heart. Biochem. J. 232: 229-236. (Pubitemid 16199005)
20. Nilsson-Ehle, P., and M. C. Schotz. 1976. A stable, radioactive substrate emulsion for assay of lipoprotein lipase. J. Lipid Res. 17: 536-541.
21. Lopez-Soriano, J., J. M. Argiles, and F. J. Lopez-Soriano. 1995. Metabolic effects of tumour necrosis factor-alpha on rat brown adipose tissue. Mol. Cell. Biochem. 143: 113-118.
22. Lopez-Soriano, J., F. J. Lopez-Soriano, G. J. Bagby, D. H. Williamson, and J. M. Argiles. 1997. Anti-TNF treatment does not reverse the abnormalities in lipid metabolism of the obese Zucker rat. Am. J. Physiol. 272: E656-E660. (Pubitemid 27194705)
23. Hohorst, H. J., F. H. Kreutz, and T. Buecher. 1959. On the metabolite content and the metabolite concentration in the liver of the rat [in German]. Biochem. Z. 332: 18-46.
24. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
25. López-Soriano, J., J. M. Argilés, and F. J. López-Soriano. 1997. Sequential changes in lipoprotein lipase activity and lipaemia induced by the Yoshida AH-130 ascites hepatoma in rats. Cancer Lett. 116: 159-165. (Pubitemid 27283003)
26. Goto, T., H. Saika, T. Takahashi, A. Maeda, M. Mune, and S. Yukawa. 1999. Erythropoietin supplement increases plasma lipoprotein lipase and hepatic triglyceride lipase levels in hemodialysis patients. Kidney Int. Suppl. 71: S213-S215. (Pubitemid 29304855)
27. Bing, C. 2011. Lipid mobilization in cachexia: mechanisms and mediators. Curr. Opin. Support. Palliat. Care. 5: 356-360.
28. Fouladiun, M., U. Korner, I. Bosaeus, P. Daneryd, A. Hyltander, and K. G. Lundholm. 2005. Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care-correlations with food intake, metabolism, exercise capacity, and hormones. Cancer. 103: 2189-2198. (Pubitemid 40605128)
29. Das, S. K., S. Eder, S. Schauer, C. Diwoky, H. Temmel, B. Guertl, G. Gorkiewicz, K. P. Tamilarasan, P. Kumari, M. Trauner, et al. 2011. Adipose triglyceride lipase contributes to cancer-associated cachexia. Science. 333: 233-238.
30. Swift, S., A. R. Ellison, P. Kassner, I. McCaffery, J. Rossi, A. M. Sinclair, C. G. Begley, and S. Elliott. 2010. Absence of functional EpoR expression in human tumor cell lines. Blood. 115: 4254-4263.